Advertisement

The History of Peroxisomal Research

  • Tsuneo ImanakaEmail author
Chapter

Abstract

Peroxisomes are subcellular organelles bounded by a single membrane. They are involved in a variety of metabolic processes, including the β-oxidation of very long chain fatty acids, as well as the synthesis of ether-phospholipids and bile acid in mammals. These organelles were first described in 1954 in the cytoplasm of the proximal tubule cells of the mouse kidney by Rhodin and were first known as “microbodies”. Subsequently, in 1965 de Duve et al. isolated microbodies from the rat liver and defined them as membrane-bound organelles containing various H2O2-producing oxidases along with H2O2-degrading catalase, and named them peroxisomes. The fatty acid β-oxidation system was identified in rat liver peroxisomes in 1976. Goldfischer discovered that peroxisomes were absent from the tissues of patients with Zellweger syndrome in 1973, and the metabolic defects that characterize this disease contributed to the elucidation of the metabolic roles of peroxisomes in humans. With regard to the biogenesis of the peroxisome in mammals, several models have been proposed and the following process is generally accepted. Pre-peroxisomes bud from the endoplasmic reticulum, and peroxisomal membrane and matrix proteins are then imported into these pre-peroxisomes. The mature peroxisomes grow by division. Here, I look back the history of peroxisomal research based on the investigation of the biogenesis and function of peroxisomes, along with peroxisomal diseases.

Keywords

Peroxisome Biogenesis Function Lipid metabolism Peroxisomal diseases 

Abbreviations

ER

Endoplasmic reticulum

PBD

Peroxisome biogenesis disorder

PMP

Peroxisomal membrane protein

RCDP

Rhizomelic chondrodysplasia punctata

VLCFA

Very long chain fatty acid

X-ALD

X-linked adrenoleukodystrophy

Notes

Acknowledgments

The publication is supported in part by a Grant-in-Aid for Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan. Pacific Edit reviewed the manuscript prior to submission.

References

  1. Agrawal G, Subramani S (2016) De novo peroxisome biogenesis: evolving concepts and conundrums. Biochim Biophys Acta 1863(5):892–901PubMedCrossRefGoogle Scholar
  2. Baudhuin P (1969) Liver peroxisomes, cytology and function. Ann N Y Acad Sci 168(2):214–228PubMedCrossRefGoogle Scholar
  3. Baudhuin P et al (1965) Combined biochemical and morphological study of particulate fractions from rat liver. Analysis of preparations enriched in lysosomes or in particles containing urate oxidase, D-amino acid oxidase, and catalase. J Cell Biol 26(1):219–243PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bernhard W, Rouiller C (1956) Microbodies and the problem of mitochondrial regeneration in liver cells. J Biophys Biochem Cytol 2(4 Suppl):355–360PubMedPubMedCentralGoogle Scholar
  5. Blaw M (1970) Melanodermic type leukodystrophy (adrenoleukodystrophy). In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 10. American Elsevier, New York, pp 128–133Google Scholar
  6. Bowen P et al (1964) A familial syndrome of multiple congenital defects. Bull Johns Hopkins Hosp 114:402–414PubMedPubMedCentralGoogle Scholar
  7. Braverman N et al (1997) Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat Genet 15(4):369–376CrossRefGoogle Scholar
  8. Breidenbach RW, Beevers H (1967) Association of the glyoxylate cycle enzymes in a novel subcellular particle from castor bean endosperm. Biochem Biophys Res Commun 27(4):462–469PubMedCrossRefGoogle Scholar
  9. Breidenbach RW et al (1968) Characterization of glyoxysomes from castor bean endosperm. Plant Physiol 43(5):705–713PubMedPubMedCentralCrossRefGoogle Scholar
  10. Cooper TG, Beevers H (1969) β oxidation in glyoxysomes from castor bean endosperm. J Biol Chem 244(13):3514–3520PubMedGoogle Scholar
  11. Datta NS et al (1984) Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes. N Engl J Med 311(17):1080–1083PubMedCrossRefGoogle Scholar
  12. de Duve C (1983) Microbodies in the living cell. Sci Am 248(5):74–84PubMedCrossRefGoogle Scholar
  13. de Duve C, Baudhuin P (1966) Peroxisomes (microbodies and related particles). Physiol Rev 46(2):323–357PubMedCrossRefGoogle Scholar
  14. Distel B et al (1996) A unified nomenclature for peroxisome biogenesis factors. J Cell Biol 135(1):1–3PubMedCrossRefGoogle Scholar
  15. Engelen M et al (2012) X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7:51PubMedPubMedCentralCrossRefGoogle Scholar
  16. Erdmann R et al (1989) Isolation of peroxisome-deficient mutants of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A 86(14):5419–5423PubMedPubMedCentralCrossRefGoogle Scholar
  17. Erdmann R et al (1991) PAS1, a yeast gene required for peroxisome biogenesis, encodes a member of a novel family of putative ATPases. Cell 64(3):499–510PubMedCrossRefGoogle Scholar
  18. Goldfischer S et al (1973) Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182(4107):62–64CrossRefGoogle Scholar
  19. Gould SG et al (1987) Identification of a peroxisomal targeting signal at the carboxy terminus of firefly luciferase. J Cell Biol 105(6 Pt 2):2923–2931PubMedCrossRefGoogle Scholar
  20. Gould SJ et al (1988) Identification of peroxisomal targeting signals located at the carboxy terminus of four peroxisomal proteins. J Cell Biol 107(3):897–905PubMedCrossRefGoogle Scholar
  21. Graham IA (2008) Seed storage oil mobilization. Annu Rev Plant Biol 59:115–142PubMedCrossRefGoogle Scholar
  22. Haanstra JR et al (2016) Biogenesis, maintenance and dynamics of glycosomes in trypanosomatid parasites. Biochim Biophys Acta 1863(5):1038–1048PubMedCrossRefGoogle Scholar
  23. Hess R et al (1965) Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature 208(5013):856–858PubMedCrossRefGoogle Scholar
  24. Higashi T, Peters T Jr (1963) Studies on rat liver catalase. I. Combined immunochemical and enzymatic determination of catalase in liver cell fractions. J Biol Chem 238:3945–3951PubMedGoogle Scholar
  25. Igarashi M et al (1976) Fatty acid abnormality in adrenoleukodystrophy. J Neurochem 26(4):851–860PubMedCrossRefGoogle Scholar
  26. Imanaka T et al (1987) Translocation of acyl-CoA oxidase into peroxisomes requires ATP hydrolysis but not a membrane potential. J Cell Biol 105(6 Pt 2):2915–2922CrossRefGoogle Scholar
  27. Imanaka T (2018) Biogenesis, the function of peroxisomes, and their role in genetic disease: with a focus on the ABC transporter. Yakugaku Zasshi 138:1067–1083PubMedCrossRefGoogle Scholar
  28. Imanaka T (2019) Biogenesis and function of peroxisomes with a focus on the ABC transporter. Biol Pharm Bull 42(5):649–665.  https://doi.org/10.1248/bpb.b18-00723PubMedCrossRefGoogle Scholar
  29. Issemann I, Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347(6294):645–650PubMedCrossRefGoogle Scholar
  30. Kase BF et al (1985) Defective peroxisomal cleavage of the C27-steroid side chain in the cerebro-hepato-renal syndrome of Zellweger. J Clin Invest 75(2):427–435PubMedPubMedCentralCrossRefGoogle Scholar
  31. Lazarow PB, de Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A 73(6):2043–2046PubMedPubMedCentralCrossRefGoogle Scholar
  32. Lazarow PB, Fujiki Y (1985) Biogenesis of peroxisomes. Annu Rev Cell Biol 1:489–530PubMedCrossRefGoogle Scholar
  33. Leighton F et al (1968) The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions. J Cell Biol 37(2):482–513PubMedPubMedCentralCrossRefGoogle Scholar
  34. Moser AE et al (1984) The cerebrohepatorenal (Zellweger) syndrome. Increased levels and impaired degradation of very-long-chain fatty acids and their use in prenatal diagnosis. N Engl J Med 310(18):1141–1146PubMedCrossRefGoogle Scholar
  35. Mosser J et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361(6414):726–730CrossRefGoogle Scholar
  36. Motley AM et al (1997) Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor. Nat Genet 15(4):377–380PubMedCrossRefGoogle Scholar
  37. Novikoff PM, Novikoff AB (1972) Peroxisomes in absorptive cells of mammalian small intestine. J Cell Biol 53(2):532–560PubMedPubMedCentralCrossRefGoogle Scholar
  38. Opperdoes FR, Borst P (1977) Localization of nine glycolytic enzymes in a microbody-like organelle in Trypanosoma brucei: the glycosome. FEBS Lett 80(2):360–364PubMedCrossRefGoogle Scholar
  39. Osumi T, Hashimoto T (1978) Enhancement of fatty acyl-CoA oxidizing activity in rat liver peroxisomes by di-(2-ethylhexyl)phthalate. J Biochem 83(5):1361–1365PubMedCrossRefPubMedCentralGoogle Scholar
  40. Purdue PE et al (1997) Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat Genet 15(4):381–384PubMedCrossRefPubMedCentralGoogle Scholar
  41. Reddy JK, Krishnakantha TP (1975) Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science 190(4216):787–789PubMedCrossRefGoogle Scholar
  42. Rhodin J (1954) Correlation of ultrastructural organization and function in normal and experimentally changed proximal convoluted tubule cells of the mouse kidney. PhD thesis.Google Scholar
  43. Scotto JM et al (1982) Infantile phytanic acid storage disease, a possible variant of Refsum’s disease: three cases, including ultrastructural studies of the liver. J Inherit Metab Dis 5(2):83–90PubMedCrossRefGoogle Scholar
  44. Shimozawa N et al (1992) A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science 255(5048):1132–1134PubMedPubMedCentralCrossRefGoogle Scholar
  45. Spranger JW et al (1971) Heterogeneity of Chondrodysplasia punctata. Humangenetik 11(3):190–212PubMedGoogle Scholar
  46. Steinberg G et al (2017) Woronin body-based sealing of septal pores. Fungal Genet Biol 109:53–55PubMedPubMedCentralCrossRefGoogle Scholar
  47. Sugiura A et al (2017) Newly born peroxisomes are a hybrid of mitochondrial and ER-derived pre-peroxisomes. Nature 542(7640):251–254PubMedCrossRefGoogle Scholar
  48. Svoboda DJ, Azarnoff DL (1966) Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol 30(2):442–450PubMedPubMedCentralCrossRefGoogle Scholar
  49. Thorp JM, Waring WS (1962) Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate. Nature 194:948–949PubMedCrossRefGoogle Scholar
  50. Trompier D, Savary S (2013) X-linked adrenoleukodystrophy. Colloquium series on the genetic basis of human disease #4, Morgan and Claypool Life Sciences, Williston, USACrossRefGoogle Scholar
  51. Tsukamoto T et al (1990) Isolation and characterization of Chinese hamster ovary cell mutants defective in assembly of peroxisomes. J Cell Biol 110(3):651–660PubMedCrossRefGoogle Scholar
  52. Tsukamoto T et al (1991) Restoration by a 35K membrane protein of peroxisome assembly in a peroxisome-deficient mammalian cell mutant. Nature 350(6313):77–81PubMedCrossRefGoogle Scholar
  53. Ulrich J et al (1978) Adrenoleukodystrophy. Preliminary report of a connatal case. Light- and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol 43(1–2):77–83PubMedCrossRefGoogle Scholar
  54. Vamecq J et al (2014) The human peroxisome in health and disease: the story of an oddity becoming a vital organelle. Biochimie 98:4–15PubMedCrossRefGoogle Scholar
  55. Wanders RJ et al (2017) Clinical and laboratory diagnosis of peroxisomal disorders. Methods Mol Biol 1595:329–342PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Faculty of Pharmaceutical SciencesHiroshima International UniversityKureJapan
  2. 2.University of ToyamaToyamaJapan

Personalised recommendations